{"ticker": {"uuid": "094fb1a3-33f2-48ae-8b20-ff05ae2ec240", "symbol": "300723", "name": "ApicHope Pharmaceutical Group Co., Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "ApicHope Pharmaceutical Faces Valuation Challenges Amid Declining Sales and Efficiency Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNbHpQa0poS3FHaVBsUWxPY0RJUkhjcDNyZEh1U1V5bFdHbXZyZkdySlVMSUpoS0tQS0N4UWhJcjd4MWJQR3BMZnMyOFliMU5fLW5NdTcyWXZydnN2LWY3UDdWdDlCLWhlVFZVbUhGVGpoZXFrZG5MbGJqS29iZDJYNlA1UC1QMUpyY0ZWUXNnb191M2JXbGZhV0JJYmcweVhLWm4weTZHTTF5MXRmZWt3YkxNclBkS19yVjZzcWw3V1FZazZiNU1FRkpoREptT3lsYjgzWl9R?oc=5", "source_name": "Markets Mojo", "published_at": "2026-07-21T00:07:11+00:00", "published_display": "21 Jul 2026 00:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in ApicHope Pharmaceutical Group Co., Ltd. CLass A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTFBJdUNrSkdEczVTcHFjcURIOVJqY2pVbVZsNUdValJnQVMwb0t6eWJxUDRxQmtIcGs3NU8xNGI4YWt3cHdIQ2UzNTY1NVpleUhhZGxFOGZvclhzbUFEMks5blVzZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-20T22:26:18+00:00", "published_display": "20 Jul 2026 22:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of ApicHope Pharmaceutical Group Co., Ltd. CLass A \u2013 SZSE:300723", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQM3V3YnpLUlBEdFVGbHRYTEdVMWhDXzVkdTI5MHJtbGpqS1JfV2Q5eVhlWElBcFRqckhmQmxnLVBQVGhOZ1NfUXQ4RU5xUEYxcXdTbTlKN3BfM3ZuNmxvbENFQmNteXlKWjVaVDhLcl80aE1zdW5ZbjRoelNKdHQ4Q0FabEg1blBRVUtPbk5pVkl5dFYxbWNleUJSRnN0Zw?oc=5", "source_name": "TradingView", "published_at": "2026-07-20T19:14:09+00:00", "published_display": "20 Jul 2026 19:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Apichope Pharmaceutical and collaborators patent GPR84 antagonists", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNYmFRTS02TjE0ZDlSQXQwbXNhemZ4cFRYaEZaU2pvb0xFaE8zX25DY2NwSXhzbDZZbnBzd3l6emVlNjU3ZlI1WklrVDlQVnQzLWkwOGUzazZmNjhNdjk1b0pGb0E3ekJ0WkppbnNEeUJYV2YtLTFlUmx1TFVBeU5oTkM2Z1RaZFRadVZoRzRxaUVEbmtTN05kY3NNc2VxSGlrN3ZqZ01vUjFOdjA?oc=5", "source_name": "BioWorld News", "published_at": "2024-07-24T07:00:00+00:00", "published_display": "24 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of ApicHope Pharmaceutical Group Co., Ltd. CLass A (SZSE:300723)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE1PNXpSanNZVXFjR3ZnekJHUHNqZ2tkUUdvU0g2UXBYcjdvTmFqQ3VreVl1bWdXbjFoWVNHd0owclY5LV9pOEtHMUV6RVZmTGEtYXhzTDlHdzNBTnp6NVVCQzVTQTgxWjVvX3RF?oc=5", "source_name": "TradingView", "published_at": "2018-03-03T02:05:51+00:00", "published_display": "03 Mar 2018 02:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ApicHope Pharmaceutical Faces Valuation Challenges Amid Declining Sales and Efficiency Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNbHpQa0poS3FHaVBsUWxPY0RJUkhjcDNyZEh1U1V5bFdHbXZyZkdySlVMSUpoS0tQS0N4UWhJcjd4MWJQR3BMZnMyOFliMU5fLW5NdTcyWXZydnN2LWY3UDdWdDlCLWhlVFZVbUhGVGpoZXFrZG5MbGJqS29iZDJYNlA1UC1QMUpyY0ZWUXNnb191M2JXbGZhV0JJYmcweVhLWm4weTZHTTF5MXRmZWt3YkxNclBkS19yVjZzcWw3V1FZazZiNU1FRkpoREptT3lsYjgzWl9R?oc=5", "source_name": "Markets Mojo", "published_at": "2026-07-21T00:07:11+00:00", "published_display": "21 Jul 2026 00:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in ApicHope Pharmaceutical Group Co., Ltd. CLass A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTFBJdUNrSkdEczVTcHFjcURIOVJqY2pVbVZsNUdValJnQVMwb0t6eWJxUDRxQmtIcGs3NU8xNGI4YWt3cHdIQ2UzNTY1NVpleUhhZGxFOGZvclhzbUFEMks5blVzZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-20T22:26:18+00:00", "published_display": "20 Jul 2026 22:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of ApicHope Pharmaceutical Group Co., Ltd. CLass A \u2013 SZSE:300723", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQM3V3YnpLUlBEdFVGbHRYTEdVMWhDXzVkdTI5MHJtbGpqS1JfV2Q5eVhlWElBcFRqckhmQmxnLVBQVGhOZ1NfUXQ4RU5xUEYxcXdTbTlKN3BfM3ZuNmxvbENFQmNteXlKWjVaVDhLcl80aE1zdW5ZbjRoelNKdHQ4Q0FabEg1blBRVUtPbk5pVkl5dFYxbWNleUJSRnN0Zw?oc=5", "source_name": "TradingView", "published_at": "2026-07-20T19:14:09+00:00", "published_display": "20 Jul 2026 19:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Apichope Pharmaceutical and collaborators patent GPR84 antagonists", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNYmFRTS02TjE0ZDlSQXQwbXNhemZ4cFRYaEZaU2pvb0xFaE8zX25DY2NwSXhzbDZZbnBzd3l6emVlNjU3ZlI1WklrVDlQVnQzLWkwOGUzazZmNjhNdjk1b0pGb0E3ekJ0WkppbnNEeUJYV2YtLTFlUmx1TFVBeU5oTkM2Z1RaZFRadVZoRzRxaUVEbmtTN05kY3NNc2VxSGlrN3ZqZ01vUjFOdjA?oc=5", "source_name": "BioWorld News", "published_at": "2024-07-24T07:00:00+00:00", "published_display": "24 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of ApicHope Pharmaceutical Group Co., Ltd. CLass A (SZSE:300723)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE1PNXpSanNZVXFjR3ZnekJHUHNqZ2tkUUdvU0g2UXBYcjdvTmFqQ3VreVl1bWdXbjFoWVNHd0owclY5LV9pOEtHMUV6RVZmTGEtYXhzTDlHdzNBTnp6NVVCQzVTQTgxWjVvX3RF?oc=5", "source_name": "TradingView", "published_at": "2018-03-03T02:05:51+00:00", "published_display": "03 Mar 2018 02:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 42, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 36.67, "latest_week": "2026-07-17", "one_week_move": -7.7, "four_week_move": 9.7, "twelve_week_move": -2.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.325403, "market_dynamics_buy_signal": false, "relative_strength": -22.540952, "fair_value_gap": 15.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.8351, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.7% over one week, +9.7% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 3}, {"label": "Markets Mojo", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-7.7% over one week, +9.7% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ApicHope Pharmaceutical Faces Valuation Challenges Amid Declining Sales and Efficiency Concerns"}], "updated_at": "2026-07-23T06:16:57.593596+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}